Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey

Yetik H., Gunay M., Sirop S., Salihoglu Z.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, cilt.253, sa.10, ss.1677-1683, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 253 Sayı: 10
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00417-014-2867-0
  • Dergi Adı: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1677-1683
  • Anahtar Kelimeler: Retinopathy of prematurity (ROP), Anti-VEGF, Bevacizumab, Intravitreal injection, ZONE-I, COUNTRIES, LASER
  • Karadeniz Teknik Üniversitesi Adresli: Hayır

Özet

To study the efficacy of intravitreal bevacizumab (IVB) injection as a single treatment for retinopathy of prematurity (ROP).